[1] |
Nagarajan RP,Costello JF.Epigenetic mechanisms in glioblastoma multiforme[J].Semin Cancer Biol,2009,19(3): 188-97.
|
[2] |
Kanai Y.Alterations of DNA methylation and clinieopathologieal diversity ofhuman cancers[J].Pathol Int,2008,58 (9):544-58.
|
[3] |
Bednarek AK,Laflin KJ,Daniel RL,et al.WWOX,a novel WW domain- containing protein mapping to human chromosome 16q23.3-24.1,a region frequently affected in breast cancer[J].Cancer Res,2000,60(8):2140-5.
|
[4] |
Iliopoulos D,Guler G,Han SY,et al.Fragile genes as biomarkers epigenetic control of WWOX and FHIT in lung,breast and bladder cancer[J].Oncogene,2005,24(9):1625-33.
|
[5] |
Wang X,Sun JZ,Chen LS,et al.WWOX gene expression and aberrant CpG island hypermethylation of WWOX gene in breast cancer[J].Zhonghua Pu Tong Wai Ke Za Zhi,2008,23(5):380-3.[王晓,孙靖中,陈连胜,等.乳腺癌WWOX基因表达缺陷的 意义及其与CpG岛甲基化的关系[J].中华普通外科杂志,2008,23(5):380-3.]
|
[6] |
Qin HR,Iliopoulos D,Semba S,et al.A role for the WWOX gene in prostate cancer[J].Cancer Res,2006,66(13):6477- 81.
|
[7] |
Yan J,Zhang M,Zhang J,et al.Helicobacter pylori infection promotes methylation of WWOX gene in human gastric cancer[J].Biochem Biophys Res Commun,2011,408 (1):99-102.
|
[8] |
Azhikina TL,Sverdlov ED.Study of tissue-specific CpG methylation of DNA in extended genomic loci[J].Biocemistry(Mosc),2005,70 (5):596-603.
|
[9] |
Surowiak P,Materna V,Maciejczyk A,et al.Decreased expression of p16 in ovarian cancers represents an unfavourable prognostic factor[J].Histol Histopathol,2008,23(5):531-8.
|
[10] |
Feng W,Marquez RT,Lu Z,et al.Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down- regulated in human ovarian cancers by loss of heterozygosity and promoter methylation [J].Cancer,2008,112(7): 1489-502.
|
[11] |
Potapova A,Hoffman AM,Godwin AK,et al.Promoter hypermethylation of PALB2 susceptibility gene in inherited and sporadic breast and ovarian cancer[J].Cancer Res,2008,68(4):998-1002.
|
[12] |
Makarla PB,Saboorian MH,Ashfaq R,et al.Promoter hypermethylation profile of ovarian epithelial neoplasms[J].Clin Cancer Res,2005,11(15):5365-9.
|
[13] |
Yan HC,Lu XY,Han QY.WWOX mRNA expression in epithelial ovarian cancer and its clinical significance[J].Xuzhou Yi Xue Yuan Xue Bao,2007,27(2):126-8.[闫洪超,陆晓媛,韩秋峪.WWOX mRNA在上皮性卵巢癌组织中的表达及临床意义[J].徐州 医学院学报,2007,27(2):126-8.]
|
[14] |
Yan HC,Xue JQ,Lu XY,et al.Effects of wwox gene transfection on cell growth of epithelial ovarian cancer[J].Zhonghua Fu Chan Ke Za Zhi,2008,43(5):361-5.[闫洪超,薛家强,陆晓媛,等.WWOX基因转染对上皮性卵巢癌细胞生长的影响[J].中华妇产科杂志,2008,43(5):361-5.]
|
[15] |
Gourley C,Paige AJ,Taylor KJ,et al.WWOX gene expression abolishes ovarian cancer tumorigenicity in vivo and decreases attachment to fibronectin via integrin α3 [J].Cancer Res,2009,69(11):4835-42.
|
[16] |
Xiong ZF,Wang ZH.Expression of WWOX protein in the epithelial ovarian carcinoma[J].Zhongguo Fu You Bao Jian,2010,25(14):1982-4.[熊宙芳,王泽华.上皮性卵巢癌组织中WWOX蛋白的表达[J].中国妇幼保健,2010,25(14):1982-4.]
|